- ￥1700 - 4000
- GeneTex
- 美国
- GTX632604
- 2025年07月14日
- WB, ICC/IF, IHC-P, IHC-Fr, FACS, IP, ELISA, EM, Neutralizing/Inhibition, Sandwich ELISA, IHC-P (cell pellet)
- Mouse
- SARS Coronavirus, SARS Coronavirus 2
企业认证
相关产品推荐更多 >
![CD64 antibody [10.1]](https://img1.dxycdn.com/2022/0328/744/3806019072906700453-14.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
The immunogen used to generate this antibody corresponds to SARS-CoV SΔ10 (within S2 domain) protein (1029-1192 a.a.). (SARS-CoV strain: Sin2774) The exact sequence is proprietary.
- 亚型：
IgG1
- 形态：
Liquid
- 保存条件：
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4℃. For long-term storage, aliquot and store at -20℃ or below. Avoid multiple freeze-thaw cycles.
- 克隆性：
Monoclonal
- 标记物：
Unconjugated
- 适应物种：
SARS Coronavirus, SARS Coronavirus 2
- 保质期：
12 months from the shipping date of the product.
- 抗原来源：
SARS Coronavirus
- 目录编号：
GTX632604
- 级别：
Primary Antibodies
- 库存：
Available
- 供应商：
GeneTex
- 宿主：
Mouse
- 应用范围：
WB, ICC/IF, IHC-P, IHC-Fr, FACS, IP, ELISA, EM, Neutralizing/Inhibition, Sandwich ELISA, IHC-P (cell pellet)
- 浓度：
1 mg/ml(Please refer to the vial label for the specific concentration.)
- 靶点：
Our internal testing indicates no cross-reactivity with MERS-CoV spike protein.This antibody is able to detect multiple SARS-CoV-2 VOCs, including Omicron variant.
- 抗体英文名：
SARS-CoV / SARS-CoV-2 (COVID-19) spike antibody [1A9]
- 抗体名：
SARS-CoV / SARS-CoV-2 (COVID-19) spike 抗体 [1A9]
- 规格：
100 μl/25 μl
| 规格： | 100 μl | 产品价格： | ￥4000.0 |
|---|---|---|---|
| 规格： | 25 μl | 产品价格： | ￥1700.0 |
Indirect ELISA analysis was performed by coating the plate with recombinant SARS-CoV-2 (COVID-19) Spike (ECD) Protein, Omicron / BA.2.12.1 variant, His tag (GTX137114-pro) (28.62-0.45 nM). Coated protein was probed with the specified SARS-CoV-2 (COVID-19) Spike antibodies (1 μg/mL). Goat anti-rabbit IgG antibody (HRP) (GTX213110-01) (1:10000) or goat anti-mouse IgG antibody (HRP) (GTX213111-01) (1:10000) were used to detect the bound primary antibodies.
SARS-CoV / SARS-CoV-2 (COVID-19) spike antibody [1A9] detects SARS-CoV-2 (COVID-19) spike protein by immunofluorescent analysis.
Sample: BHK-21 cells transfected with full-length SARS-CoV-2 spike were fixed in 4% PFA at RT for 30 min.
Green: SARS-CoV-2 (COVID-19) spike stained by SARS-CoV / SARS-CoV-2 (COVID-19) spike antibody [1A9] (GTX632604) diluted at 1:2000.
Sandwich ELISA detection of recombinant full-length SARS-CoV-2 spike (trimer) protein using GTX632604 as capture antibody at concentration of 5 μg/mL and GTX635672 as detection antibody at concentration of 1 μg/mL. Rabbit IgG antibody (HRP) (GTX213110-01) was diluted at 1:10000 and used to detect the primary antibody.
Indirect ELISA analysis was performed by coating the plate with recombinant SARS-CoV-2 spike (ECD) trimer, omicron BA.2.75 variant, His tag (GTX137533-pro) (28.62-0.45 nM). Coated protein was probed with SARS-CoV / SARS-CoV-2 (COVID-19) spike antibody [1A9] (the specified SARS-CoV-2 (COVID-19) Spike antibodies) (1 μg/mL). Goat anti-mouse IgG antibody (HRP) (GTX213111-01) (1:10000) was used to detect the bound primary antibody.
Non-transfected (–) and transfected (+) 293T whole cell extracts (30 μg) were separated by 10% SDS-PAGE, and the membrane was blotted with SARS-CoV / SARS-CoV-2 (COVID-19) spike antibody [1A9] (GTX632604) diluted at 1:5000. The HRP-conjugated anti-mouse IgG antibody (GTX213111-01) was used to detect the primary antibody.
Immunoprecipitation of SARS-CoV-2 Spike transfected 293T whole cell extracts using 2 μg of SARS-CoV / SARS-CoV-2 (COVID-19) spike antibody [1A9] (GTX632604).
Western blot analysis was performed using SARS-CoV / SARS-CoV-2 (COVID-19) spike antibody [1A9] (GTX632604).
EasyBlot HRP-conjugated anti mouse IgG antibody (GTX221667-01) was used to detect the primary antibody.
Indirect ELISA analysis was performed by coating the plate with recombinant SARS-CoV-2 (COVID-19) Spike (ECD) Protein, BA.2 / Omicron variant, His tag (GTX137037-pro) (29.71-0.46 nM). Coated protein was probed with the specified SARS-CoV-2 (COVID-19) Spike antibodies (1 μg/mL). Goat anti-rabbit IgG antibody (HRP) (GTX213110-01) (1:10000) or goat anti-mouse IgG antibody (HRP) (GTX213111-01) (1:10000) were used to detect the bound primary antibodies.
Sandwich ELISA detection of non-transfected (GTX535673) and SARS-CoV-2 spike (full length) transfected (GTX535664) 293T whole cell extracts using GTX632604 as capture antibody at concentration of 5 μg/mL and GTX135356 as detection antibody at concentration of 1 μg/mL. Rabbit IgG antibody (HRP) (GTX213110-01) was diluted at 1:10000 and used to detect the primary antibody.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Jakob Trimpert et al., Cell Rep 2021 (PMID:34320400)
Dickson W L Wong et al., Cells 2021 (PMID:34440669)
Caterina Prelli Bozzo et al., Nat Commun 2021 (PMID:34321474)
Drucilla J Roberts et al., Am J Obstet Gynecol 2021 (PMID:34364845)
Elaine C Chen et al., Cell Rep 2021 (PMID:34411541)
Abhijith Biji et al., EBioMedicine 2021 (PMID:34392148)
Xiangchuan He et al., Emerg Microbes Infect 2021 (PMID:34304724)
Fabian Zech et al., Nat Commun 2021 (PMID:34824253)
Shahanshah Khan et al., Elife 2021 (PMID:34866574)
Sung-Chan Wei et al., Front Immunol 2021 (PMID:35003088)
Marica Grossegesse et al., J Proteome Res 2022 (PMID:34982558)
Kah-Whye Peng et al., Vaccine 2022 (PMID:35282925)
Ravindra Gupta et al., Res Sq 2022 (PMID:35075452)
Pehu?n Pereyra Gerber et al., PLoS Pathog 2022 (PMID:35143592)
Hang Yang et al., Virol Sin 2022 (PMID:35272059)
Andreia L Pinto et al., Nat Commun 2022 (PMID:35338134)
Ningfei Ji et al., Emerg Microbes Infect 2022 (PMID:35343389)
Chan Maung Nyein et al., J Hepatol 2022 (PMID:35439566)
Hiroki Hayashi et al., Curr Res Transl Med 2022 (PMID:35489099)
Daichi Yamasoba et al., Cell 2022 (PMID:35568035)
Irina Panina et al., Int J Mol Sci 2022 (PMID:35563480)
Alice Mac Kain et al., Nat Commun 2022 (PMID:35508460)
Michael S Nirenberg et al., J Cutan Pathol 2022 (PMID:35366017)
E Welsh et al., J Eur Acad Dermatol Venereol 2022 (PMID:35471706)
Katharina R?ltgen et al., Cell 2022 (PMID:35148837)
Marco A D?az-Salinas et al., Elife 2022 (PMID:35323111)
Andres Santos et al., Mod Pathol 2022 (PMID:35361888)
Bo Meng et al., Nature 2022 (PMID:35104837)
Shahzaib Ahamad et al., Front Genet 2022 (PMID:35401674)
Yi-Chung Chang et al., EMBO Mol Med 2022 (PMID:35138028)
Veronica Bordoni et al., iScience 2022 (PMID:35128349)
Valeria Garcia-Flores et al., Nat Commun 2022 (PMID:35042863)
Wenrui Guo et al., Life Sci Alliance 2022 (PMID:35110354)
Junyuan Cao et al., Viruses 2022 (PMID:35215943)
Silvia C Trevelin et al., Front Immunol 2022 (PMID:35251032)
Yasuo Ariumi et al., J Virol 2022 (PMID:35107372)
Nicola Wanner et al., Nat Metab 2022 (PMID:35347318)
Anna Riccio et al., Cell Mol Life Sci 2022 (PMID:35391601)
Baris Boyraz et al., Hum Pathol 2022 (PMID:35405186)
Michihito Sasaki et al., mBio 2021 (PMID:34425707)
Rakesh Kulkarni et al., PLoS One 2021 (PMID:34499677)
Xiaoquan Li et al., PLoS Pathog 2021 (PMID:34478458)
Carmen Mirabelli et al., Proc Natl Acad Sci U S A 2021 (PMID:34413211)
Tsuguhisa Nakayama et al., Cell Rep Med 2021 (PMID:34604819)
Shu Liu et al., Nat Commun 2021 (PMID:34667166)
Riccardo De Santis et al., J Photochem Photobiol 2021 (PMID:34729540)
Kasopefoluwa Y Oguntuyo et al., mBio 2021 (PMID:33593976)
Hsu-Yu Chen et al., J Virol 2021 (PMID:34495700)
Barbara Storti et al., Comput Struct Biotechnol J 2021 (PMID:34745450)
Marta De Angelis et al., Biomedicines 2021 (PMID:34829949)
Biering SB et al., bioRxiv 2021 (PMID:34931188)
Singh RD et al., Biochim Biophys Acta Mol Basis Dis 2022 (PMID:34920080)
Zhao L et al., MedComm (2020) 2021 (PMID:34909756)
Song J et al., bioRxiv 2021 (PMID:34845449)
Dorman LC et al., bioRxiv 2022 (PMID:35233577)
Ramadan AA et al., Viruses 2022 (PMID:35336938)
Magalh?es AC et al., Pathogens 2022 (PMID:35335638)
Gehlhausen JR et al., Proc Natl Acad Sci U S A 2022 (PMID:35217624)
Neuberger M et al., Infection 2022 (PMID:35182354)
Matsuoka K et al., J Biol Chem 2022 (PMID:35157849)
Suzuki R et al., Nature 2022 (PMID:35104835)
Kung YA et al., mBio 2022 (PMID:35038927)
Yokoi S. et al., Eur J Dermatol. 2021 (PMID:34405810)
Kim Y et al., Cell Mol Immunol 2022 (PMID:34992275)
Wan L et al., Nat Metab 2022 (PMID:34992299)
Fenizia C et al., Microbiol Spectr 2022 (PMID:34985303)
Tada T et al., Cell Rep 2022 (PMID:34982967)
Kongsuphol P. et al., Communications Medicine 2021 (Epub)
Zhang Z et al., Cell Death Differ 2021 (PMID:33879858)
Rosner-Tenerowicz A et al., BMC Pregnancy Childbirth 2021 (PMID:34758757)
Al-Beltagi S et al., Virulence 2021 (PMID:34793280)
Ohtsuka J et al., iScience 2021 (PMID:34805782)
Saito A et al., Nature 2021 (PMID:34823256)
Kim M et al., Biomedicines 2021 (PMID:34829954)
Zhong C et al., NPJ Vaccines 2021 (PMID:34845215)
Xiao Y et al., Cell 2021 (PMID:34852237)
Zhao L. et al., MedComm 2021 (Epub)
Shue B et al., J Virol 2021 (PMID:34586867)
Johnson JE et al., Am J Pathol 2021 (PMID:34599881)
Carter-Timofte ME et al., ACS Infect Dis 2021 (PMID:34658235)
Kudose S et al., J Am Soc Nephrol 2021 (PMID:34670811)
Ren H et al., Biol Direct 2021 (PMID:34674770)
Tada T et al., iScience 2021 (PMID:34723159)
Kim DH et al., Sci Rep 2021 (PMID:34728736)
Thyrsted J et al., iScience 2021 (PMID:34746710)
Seo JS et al., Viruses 2021 (PMID:34452517)
Gomes I et al., Lancet Reg Health Am 2021 (PMID:34485969)
COVID-19 infection. Nature Scientifc Reports 2:MacMullan,MA et al. (2020) ELISA detection of SARS-CoV-2 antibodies in saliva. Nature Scientifc Reports 3:Hettegger,P et al. (2019) High similarity of IgG antibody profles in blood and saliva opens
Cell Death Differ：中大五院黄曦团队发现新冠病毒引起肺损伤的分子机制
近期，中山大学附属第五医院黄曦团队报道了 SARS-CoV-2 的 membrane (M) 蛋白通过靶向并抑制胞内 BOK 的泛素化降解，激活肺上皮细胞线粒体凋亡途径而引起肺损伤，该发现为 COVID-19 的靶向治疗提供了潜在靶点。 图片来源：Cell death & differentiation SARS-CoV-2 感染已经导致全球数以百万人的死亡，其中大部分死亡患者出现呼吸困难，肺部出现大量凋亡的细胞和渗漏的粘液，已有研究证实 SARS-CoV-2 感染引起肺细胞凋亡参与上述
中科院高福院士课题组 2020 年发表了哪些重要的研究成果？
：Science 9、Science 后再发 Nature！筛选出又一新冠病毒治疗性单克隆中和抗体DOI: 10.1038/s41586-020-2381-y继之前发表在 Science 上报道筛选出新冠病毒中和抗体后，2020 年 5 月 26 日，高福院士再次联合严景华等人在 Nature 发文：A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2。该研究报告了从 COVID-19 恢复期的患者中分离出两
技术资料暂无技术资料 索取技术资料
